About 11,000 people around the world died from COVID-19 during the week of Sept. 5 to 11, a drop of 22 percent from the previous week
WHO Guideline Advises Against Fluvoxamine, Colchicine for COVID-19
For nonsevere COVID-19, 11th version of living guideline recommends against fluvoxamine (except in context of clinical trial), colchicine
Living Guideline Updated for Drug Treatment of COVID-19
Tenth version recommends nirmatrelvir/ritonavir in patients with confirmed COVID-19 who have highest risk for hospitalization
In Reversal, WHO Now Supports COVID-19 Boosters
Number of studies show that booster doses help restore weakening immunity and protect against severe COVID-19
Molnupiravir for Nonsevere COVID-19 Added to Living Guideline
Molnupiravir recommended only for those at highest risk for hospitalization given its potential long-term harms
WHO Says Worst of Pandemic Could Ease This Year if Vaccine Inequities Erased
Fewer than 10 percent of people in lower-income countries have received one dose of COVID-19 vaccine
WHO Living Guideline Updated for Drug Treatment of COVID-19
JAK inhibitor baricitinib strongly recommended for the treatment of severe or critical COVID-19
Convalescent Plasma Not Recommended in COVID-19
Guideline Development Group strongly recommends against its use in nonsevere COVID-19, recommends against use in severe, critical illness
Climate Change Is World’s Most Pressing Health Problem: WHO
WHO report and open letter signed by health professionals outline major climate issues affecting public health
WHO Says Africa Will Get 30 Percent of COVID-19 Vaccines It Needs by February
African Union envoy for COVID-19 vaccines said export restrictions and intellectual property rights should be lifted to allow vaccine production within Africa
- Page 1 of 2
- 1
- 2